Friday, November 22

Tag: CANCER TREATMENT

Chicago-based Tempus Raises $110 Million in Series E Funding Round
30Aug By Gauri SinghNo Comments
FUNDING

Chicago-based Tempus Raises $110 Million in Series E Funding Round

Chicago-based data analytics startup Tempus has raised funds amounting to $110 million in its Series E funding round. The funding round was led by a new backer Baillie Gifford, a U.K. investment management firm. The other investors who participated in the round included existing investors T. Rowe Price, Revolution Growth and New Enterprise Associates. With the funds raised through this round, the company plans to grow operations outside of the U.S. and also expand into new therapeutic areas other than cancer. This particular round has valued the company to over $2 billion. Following this round, the total funds raised by the company as of now has reached $320 million since its launch. Founded in 2015 by serial entrepreneur Eric Lefkofsky, Tempus is a data analytics company that ...
Read More
OncoStem Diagnostics Raises $6 Mn Funding From Sequoia Capital
6Sep By AnkitaNo Comments
FUNDING

OncoStem Diagnostics Raises $6 Mn Funding From Sequoia Capital

Bengaluru based oncology startup, OncoStem Diagnostics, has recently raised $6 million from VC firm Sequoia Capital India Advisors, a senior executive of the company said. OncoStem focuses on  personalized cancer treatment planning through the development of tests that try to effectively predict the chance of cancer recurrence in patients. It was founded by Manjiri Bakre in 2011. The startup earlier raised its first funding in 2011 from California-based VC firm Artiman Ventures which invested $3 million in the company in multiple tranches. “There are no affordable tests in India to accurately predict the risk of cancer recurrence. We aim to develop innovative and cost-effective tests that will help predict and assess the risk of recurrence in cancer patients, thus providing doctors ...
Read More